Elevated serum interleukin-10 at time of hospital admission is predictive of mortality in patients with staphylococcus aureus bacteremia

Journal of Infectious Diseases

Volumn 206, Issue 10, 2012, Pages 1604-1611

  Rose, Warren E ^a   Eickhoff, Jens C ^b   Shukla, Sanjay K ^c   Pantrangi, Madhulatha ^c   Rooijakkers, Suzan ^d   Cosgrove, Sara E ^e   Nizet, Victor ^f,g   Sakoulas, George ^f  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c MARSHFIELD CLINIC   (United States)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^g UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; COMPLEMENT MEMBRANE ATTACK COMPLEX; INTERLEUKIN 10; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BLOOD SAMPLING; CLINICAL FEATURE; CYTOKINE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MORTALITY; NONHUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STAPHYLOCOCCAL BACTEREMIA; SURVIVAL; TREATMENT DURATION; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; AGING; BACTEREMIA; BIOLOGICAL MARKERS; COMPLEMENT MEMBRANE ATTACK COMPLEX; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITALIZATION; HUMANS; INTERLEUKIN-10; INTERLEUKIN-1BETA; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84867733152     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis552     Document Type: Article

References (16)

1. van Dissel JT, van Langevelde P, Westendorp RG, Kwappenberg K, Frolich M. Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet 1998; 351:950-3.
2. Chau TA, McCully ML, Brintnell W, et al. Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndrome. Nat Med 2009; 15:641-8.
3. Frodermann V, Chau TA, Sayedyahossein S, Toth JM, Heinrichs DE, Madrenas J. A modulatory interleukin-10 response to staphylococcal peptidoglycan prevents Th1/Th17 adaptive immunity to Staphylococcus aureus. J Infect Dis 2011; 204:253-62.
4. Jongerius I, Kohl J, Pandey MK, et al. Staphylococcal complement evasion by various convertase-blocking molecules. J Exp Med 2007; 204:2461-71.
5. Cerquetti MC, Sordelli DO, Ortegon RA, Bellanti JA. Impaired lung defenses against Staphylococcus aureus in mice with hereditary deficiency of the fifth component of complement. Infect Immun 1983; 41:1071-6.
6. von Kockritz-Blickwede M, Konrad S, Foster S, Gessner JE, Medina E. Protective role of complement C5a in an experimental model of Staphylococcus aureus bacteremia. J Innate Immun 2009; 2:87-92.
7. Spika JS, Peterson PK, Wilkinson BJ, et al. Role of peptidoglycan from Staphylococcus aureus in leukopenia, thrombocytopenia, and complement activation associated with bacteremia. J Infect Dis 1982; 146:227-34.
8. Howden BP, Smith DJ, Mansell A, et al. Different bacterial gene expression patterns and attenuated host immune responses are associated with the evolution of low-level vancomycin resistance during persistent methicillin-resistant Staphylococcus aureus bacteraemia. BMC Microbiol 2008; 8:39.
9. Soriano A, Marco F, Martinez JA, et al. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 2008; 46:193-200.
10. Holmes NE, Turnidge JD, Munckhof WJ, et al. Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations. J Infect Dis 2011; 204:340-7.
11. Clinical and Laboratory Standards Institute. 20th informational supplement (M100-S20). Wayne, PA: Clinical and Laboratory Standards Institute, 2010. Performance standards for antimicrobial susceptibility testing.
12. Koreen L, Ramaswamy SV, Graviss EA, Naidich S, Musser JM, Kreiswirth BN. spa typing method for discriminating among Staphylococcus aureus isolates: implications for use of a single marker to detect genetic micro-and macrovariation. J Clin Microbiol 2004; 42:792-9.
13. Mellmann A, Weniger T, Berssenbrugge C, et al. Based Upon Repeat Pattern (BURP): an algorithm to characterize the long-term evolution of Staphylococcus aureus populations based on spa polymorphisms. BMC Microbiol 2007; 7:98.
14. Breiman L, Friedman J, Stone CJ, Olshen RA. Classification and regression tress. Monterey, CA: Wadsworth International Group, 1984.
15. Gasche Y, Pascual M, Suter PM, Favre H, Chevrolet JC, Schifferli JA. Complement depletion during haemofiltration with polyacrilonitrile membranes. Nephrol Dial Transpl 1996; 11:117-9.
16. Koller H, Hochegger K, Zlabinger GJ, Lhotta K, Mayer G, Rosenkranz AR. Apoptosis of human polymorphonuclear neutrophils accelerated by dialysis membranes via the activation of the complement system. Nephrol Dial Transpl 2004; 19:3104-11.